Meta-Analysis on the Efficacy and Safety of Xueshuantong for Coronary Heart Disease

Yu Zheng,Lao Yongxin,Huang Zhanwen

DOI: https://doi.org/10.3969/j.issn.1673-5846.2013.04.005

2013-01-01

Abstract:Objective To evaluate efficacy and safety of Xueshuantong for coronary heart disease,from which to provide scientific proofs for clinical decision making.Methods We firstly retrieved and selected literatures,and the methodological quality evaluation of the included articles was followed.Afterwards,using Cochrane Collaboration's software RevMan 5.0,we conducted Meta-analysis with fixed or random effect model.Results A total of thirty one papers were included in the study and the methodological quality was graded to C.When it comes to electrocardiogram total response rate,RRs and 95%CI were 1.45(1.29～1.62),1.19(1.01～1.41),1.22(1.10～1.34),1.28(1.19～1.38)which indicated there were significant differences between Xueshuantong alone and Fufang Danshen alone,Xueshuantong+other drugs combination and Fufang Danshen+other drugs combination,Xueshuantong+Nitroglycerinum combination and Nitroglycerinum alone,Xueshuantong+other drugs combination and other drugs.As for angina total response rate,Significance differences were noted between Xueshuantong+other drugs combination and other drugs,Xueshuantong+Nitroglycerinum combination and Nitroglycerinum alone where RRs and 95%CI were 1.28(1.19～1.38),1.30(1.15～1.48).The sensitivity analysis tested and verified the reliability of the results above.Conclusions The adoption of Xueshuantong for coronary heart disease can improve total response rate.